Home > News > Top Chinese scientist receives prestigious British chemistry society's highest honor
December 14th, 2007
Top Chinese scientist receives prestigious British chemistry society's highest honor
One of China's top chemists, Bai Chunli, becomes the first Chinese scientist honored by the Royal Society of Chemistry (RSC) of the United Kingdom for his innovative research on chemistry.
Richard Pike, RSC chief executive officer, granted the certificates of the honorary fellow of the RSC to Bai in Beijing, the Chinese Academy of Sciences (CAS) website reported on Friday.
Bai is among the 87 global academic celebrities, including a handful of Nobel laureates in chemistry, to earn the extraordinary honor. The RSC constitution stipulates the total number of honorary fellows should be no more than 120 and they must undergo a rigorous nomination and election process.
The 54-year-old chemist, deputy CAS president and president of the Chinese Chemical Society, is leading the most cutting-edge research on molecular nanostructure and nanotechnology in China, which earned him election in April 2006 as the elite foreign associate of the U.S. National Academy of Sciences (NAS).
MIG Takes a Roll-Up-Your-Sleeves Approach with Revamped MEMS/Sensors Technical Event -- MIG welcomes technologists to MEMS Technical Congress, emphasizes working groups and breakout sessions on emerging MEMS & sensors, tech transfer and integration March 6th, 2015
Phenom-World announces the Phenom XL, world’s fastest desktop SEM to handle large samples March 6th, 2015
Air Bearing Stage / Systems Introduced by PI at Photonics West March 6th, 2015
Get ready for NanoDays! March 5th, 2015
Anousheh Ansari Wins the National Space Society's Space Pioneer Award for "Service to the Space Community" March 5th, 2015
Enhanced Graphene Components for Next Generation Racing Yacht March 5th, 2015
Rice's Stephan Link honored for nanoscience research: The Welch Foundation honors ‘rising star’ with $100,000 Hackerman Award February 26th, 2015
Cutting-edge technology optimizes cancer therapy with nanomedicine drug combinations: UCLA bioengineers develop platform that offers personalized approach to treatment February 24th, 2015